ASXL1与CSF3R双突变驱动髓系偏向性干细胞扩增并增强中性粒细胞分化
研究构建同时携带Asxl1Y588X与Csf3rT621I突变的小鼠模型,发现Csf3r突变导致年龄相关造血干细胞耗竭,加入Asxl1Y588X后该耗竭减轻,双突变引起髓系偏向性长期造血干细胞扩增,小鼠出现中性粒细胞增多但白血病罕见。机制上Asxl1截短增强CSF3RT618I驱动的中性粒细胞分化,双突变细胞中性粒细胞相关增强子H3K4me1增加,且CSF3R突变可逆转Asxl1突变细胞中H2AK119ub的预期下降。
要点
- 双突变小鼠出现髓系偏向性长期造血干细胞扩增并发生中性粒细胞增多,但白血病罕见。
- Asxl1Y588X可减轻Csf3r突变小鼠年龄相关的造血干细胞耗竭。
- Asxl1截短增强CSF3RT618I驱动的中性粒细胞分化并激活炎症通路。
核心结论
- ASXL1突变在髓系疾病中呈现依赖突变背景的效应,双突变MPN中性粒细胞分化的机制涉及炎症通路与染色质动态改变。
研究设计与样本
- 研究构建同时携带Asxl1Y588X与Csf3rT621I突变的小鼠模型,用于重现人类MPN特征。
主要发现
- Csf3r突变小鼠出现年龄相关的造血干细胞耗竭,加入Asxl1Y588X后该耗竭被减轻。
- 双突变导致髓系偏向性长期造血干细胞扩增,小鼠随年龄增长出现中性粒细胞增多,但白血病罕见,提示转化可能需要额外突变。
- 在髓系分化模型中,Asxl1截短增强CSF3RT618I驱动的中性粒细胞分化,并激活与成熟髓系细胞产生相关的炎症通路。
- 双突变细胞中性粒细胞相关增强子处H3K4me1增加。
- Asxl1突变细胞中H2AK119ub按预期下降,但同时携带CSF3R突变时该效应被逆转。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mutations in the epigenetic regulator Additional Sex Combs-Like 1 (ASXL1) are frequently observed in chronic neutrophilic leukemia (CNL). CNL is a myeloproliferative neoplasm (MPN) driven by activating mutations in the Colony Stimulating Factor 3 Receptor (CSF3R), which cause excessive neutrophil production. Despite the high rates of co-occurrence, the interplay between ASXL1 and CSF3R mutations in hematopoiesis and leukemia remains poorly understood. Here, we present a new mouse model with both Asxl1Y588X and Csf3rT621I mutations, which recapitulates features of human MPNs. Csf3r-mutant mice exhibit an age-associated depletion of hematopoietic stem cells, which is tempered by adding Asxl1Y588X. This combination of mutations causes an expansion of myeloid-biased long-term hematopoietic stem cells. As the mice age, they develop neutrophilia, but leukemia is rare, suggesting additional mutations may be required for transformation. Using models of myeloid differentiation, we find that Asxl1 truncation enhances CSF3RT618I-driven neutrophil differentiation, activating inflammatory pathways associated with mature myeloid cell production. Moreover, cells with both mutations have increased H3K4me1 at neutrophil-associated enhancers. Mutant ASXL1 is known to decrease the genome-wide abundance of the repressive histone mark H2AK119ub. Although we see the expected decrease in H2AK119ub in Asxl1-mutant cells, this effect is reversed when CSF3R is also mutated, suggesting a complex interplay between these mutations in regulating chromatin dynamics during hematopoiesis. Our findings highlight context-dependent effects of ASXL1 mutation in myeloid disorders and provide insights into the mechanisms underlying neutrophil differentiation in ASXL1 and CSF3R dual-mutant MPN.
引用
- Darmusey L, Bagley AJ, Nguyen TT, et al. Dual ASXL1 and CSF3R mutations drive myeloid-biased stem cell expansion and enhance neutrophil differentiation. Blood Adv. 2025. PMID: 39777477. doi:10.1182/bloodadvances.2024014362
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。